在患有三阴性乳腺癌的患者中,布罗利祖马布诱导的燃烧性心肌炎
Adnan Shaaban1, Alma Habib2, Dionisia Quiroga2
1Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA; Cardio-Oncology Program, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
JACC. Case reports
|May 9, 2025
概括
免疫检查点抑制剂 (ICI) 可以在三阴性乳腺癌 (TNBC) 患者中引起心肌炎. 本报告详细介绍了两例亚临床或燃烧性心肌炎的病例,与TNBC中布罗利祖马布治疗有关.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 免疫检查点抑制剂 (ICI) 与化疗相结合已被批准用于治疗三阴性乳腺癌 (TNBC).
- ICI诱导的心肌炎是一种罕见但严重的并发症,死亡率高.
- 由于表现和疾病严重程度各异,诊断ICI诱导心肌炎是很困难的.
更多相关视频
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


